Prostate Cancer Market

Jun 11, 2020

10 likes | 24 Views

The total prevalent cases of Prostate Cancer in the 7MM is expected to be 7,494,882 in 2020, and are expected to increase during the study period. The market size of Prostate Cancer is expected to grow at a CAGR of 8.1% during the study period 2017-2030. Increasing use of biomarker testing, rising geriatric population and high prevalence rate of prostate cancer, surge in awareness regarding the treatment of prostate cancer, increase in demand for prostate cancer treatment products are some of the key factors expected to drive the Prostate Cancer market in the upcoming years. AstraZeneca, Bristol-Myers Squibb, Novartis, Myovant Sciences, Janssen Research & Development, Hinova Pharmaceuticals USA, Hoffmann-La Roche, Pfizer/Astellas Pharma, Clovis Oncology, Advantagene Inc., and Merck Sharp & Dohme along with others are the major pharma companies working to fuel the Prostate Cancer market.<br>For more detailed information on Prostate Cancer Market, visit: https://www.delveinsight.com/report-store/prostate-cancer-market<br><br><br>

DelveInsight

Download Presentation

Prostate Cancer Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D